ANALYSIS OF THE NEWBORNS FROM HIV POSITIVE-MOTHERS IN A PERIOD OF THREE YEARS FROM THE REGIONAL HIV-AIDS CENTER IASI, ROMANIA

https://www.doi.org/10.22551/MSJ.2021.01.06

  • MIHAI Ioana Florina “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • LACATUSU Georgiana Alexandra “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • DOROBAT Carmen “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • BAHNA Adriana Florina “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • LOGHIN Isabela “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • LARGU Alexandra “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • MANCIUC Carmen “Grigore T. Popa” University of Medicine and Pharmacy Iasi
Keywords: MATERNAL-FETAL TRANSMISSION, ANTIRETROVIRAL THERAPY, PROFYLAXIS, HIV

Abstract

Aim: With proper medication and regular monitoring, pregnant women with human immunodeficiency virus (HIV) can give birth to a healthy child. With the implementation of programs to prevent vertical transmission, the number of HIV-positive newborns has decreased significantly. The aim of this paper is to evaluate the HIV status of newborns perinatally exposed through the infection. Material and methods: We conduct a retrospective study on the HIV positive women registered at the “Sf. Parascheva” Infectious Disease Hospital from Iasi, which became mothers between 2017-2019. Results: During the three years mentioned period, 101 newborns from HIV positive mothers were included in the study, four being from untreated mothers. All the children received prophylactic antiretroviral compounds. At the end of the monitored period, two children had detectable viremia. Conclusions: Evaluation of HIV-positive mothers and prophylaxis of newborns during the evaluated period, which was conducted according to the protocol, lead to a low percentage of HIV-positive children.

Author Biographies

MIHAI Ioana Florina, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Medical Specialties (II)
“Sf. Parascheva” Infectious Disease, Iasi, Romania

LACATUSU Georgiana Alexandra, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Medical Specialties (II)
“Sf. Parascheva” Infectious Disease, Iasi, Romania

DOROBAT Carmen, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Medical Specialties (II)
“Sf. Parascheva” Infectious Disease, Iasi, Romania

BAHNA Adriana Florina, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Medical Specialties (II)
“Sf. Parascheva” Infectious Disease, Iasi,

LOGHIN Isabela, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Medical Specialties (II)
“Sf. Parascheva” Infectious Disease, Iasi, Romania

LARGU Alexandra, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Medical Specialties (II)
“Sf. Parascheva” Infectious Disease, Iasi, Romania

MANCIUC Carmen, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Medical Specialties (II)
“Sf. Parascheva” Infectious Disease, Iasi, Romania

References

1. Dorobat CM, Dorobat G, Bejan C, et al. Antibiotic therapy in severe sepsis in HIV-positive patients. Rev Med Chir Soc Med Nat Iasi 2012; 116(3): 114-117.
2. Mugo NR, Heffron R, Donnell D, et al. Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1 serodiscordant couples. AIDS (London, England) 2011; 25(15): 1887.
3. Drake AL, Wagner A, Richardson B, John-Stewart G. Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis. PLoS Med 2014; 11(2): e1001608.
4. Luca L. Autoreferat: Transmiterea materno-fetală a infecției HIV / SIDA și tratamentul profilactic, Chișinău, 2007.
5. Manciuc C, Dorobat CM, Danaila C. Lymphoma in an HIV-positive patient. Rev Med Chir Soc Med Nat Iasi 2014; 119(1): 97-100.
6. Andrioni F. Trends of HIV/AIDS Phenomenon Dynamics in Romania from 2017–2027. Iranian Journal of Public Health 2019; 48(10): 1903.
7. Global AIDS monitoring 2018: indicators for monitoring the 2016 United Nations Political Declaration on HIV and AIDS. Geneva: UNAIDS; 2018 http://www.unaids.org/sites/default/files/media_asset/2017-Global-AIDS-Monitoring_en.pdf (accessed 07 August 2020)
8. Manciuc C, Nicu M, Largu A, et al. Sustainable development and key health trends: Case study of dislipidemy in HIV patients. Environ Engin Managem J 2010; 9(4): 495-502.
9. Mitran M, Mărdărescu M, Pană PD. Naşterea la gravida HIV-pozitivă. Bucureşti: Editura Versa Puls Media, 2011.
10. Hersh BS, Popovici F, Zolotusca L, et al. The epidemiology of HIV and AIDS in Romania. AIDS 1990; 5: 87-92.
11. Craft SM, Delaney RO, Bautista DT, Serovich JM. Pregnancy decisions among women with HIV. AIDS and Behavior 2007; 11(6): 927-935.
12. Manciuc C, Filip-Ciubotaru F, Bădescu A, Largu AM. The patient-doctor-psychologist triangle in a case of severe immunosuppression in the HIV infection. Rev Med Chir Soc Med Nat Iasi 2016; 120(1): 119-123.
13. Lesser J, Oakes R, Koniak-Griffin D. Vulnerable adolescent mothers perceptions of maternal role and HIV risk. Health Care for Women International 2013; 24(6): 513-528.
14. Stănculeţ N, Grigoraş A, Predescu O, et al. Operational scores in the diagnosis of chronic hepatitis. A semi-quantitative assessment. Rom J Morphol Embryol 2012; 53(1): 81-87.
15. Manciuc C, Largu A. Impact and risk of institutionalized environments on the psycho-emotional development of the HIV-positive youth. Environ Eng Manag J 2014; 13(12): 3123-3129.
16. Manciuc C, Nicolau C, Vâţă A, et al. Mother to child HIV transmission in the North-East of Romania. Therap Pharmacol Clin Toxicol 2010; 14(2): 100-102.
17. Alidina Z, Wormsbecker AE, Urquia M, et al. HIV prophylaxis in high-risk newborns: an examination of sociodemographic factors in an inner-city context. Can J Infect Dis Med Microbiol 2016; 2016: 2782786.
18. Taha TE, Kumwenda NI, Gibbons A, et al. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomized clinical trial. The Lancet 2003; 362(9391): 1171-1177.
19. Barbosu CM, Radulescu A, Manciuc C, Muir E, Levandowski BA, Dye T. Attitudes, practices, and priority of HIV screening and testing among clinical providers in Transylvania and Moldavia, Romania. BMC Health Services Research 2019; 19(1): 970.
20. Manciuc C, Levandowski BA, Muir E, Radulescu A, Barbosu CM, Dye T. Access to digital and social media among Romanian HIV/AIDS clinical providers. Glob Health Action 2018; 11(1): 1513445.
Published
2021-03-30
Section
INTERNAL MEDICINE - PEDIATRICS